Abstract
The way in which the Food and Drug Administration (FDA) regulates new drug development is covered. Each stage—clinical studies, the new drug application, after approval of the new drug application —is described in detail. A drug development time line is included.
Keywords
Get full access to this article
View all access options for this article.
References
1.FDA.
From Test Tube to Patient: New Drug Development in the United States . FDA Consumer Special Report. March 1990 .
2.
21 CFR 312.
3.FDA.
From Test Tube to Patient: New Drug Development in the United States . FDA Consumer Special Report. 2nd ed. January 1995 .
4.FDA.
New Drug Evaluation Guidance: Refusal to File . July 12, 1993 .
5.
21 CFR 314.
6.
Brown
MS
Richard
BW
. Advisory Committees and the Drug Approval Process . J Clin Res Drug Dev.
1988 ;2 :15 –27 .
7.
Barr
D
. The Changing Approval Process: Preapproval Inspection . Food Drug Law J.
1992 ;47 : 359 –362 .
8.
21 CFR 314.80.